Login:

username:
password:

New to sessions.thyroid.org?

Create Account

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Conference

Do I Have Access?

Access:

Availability:

Browse by: Sort by:
<< first | < prev next > | last >>
presentations: 1 to 25 of 484
page: of 20 per page
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
ATA Satellite Symposium Welcome Remarks
Charles H. Emerson, MD
University of Massachusetts School of Medicine, Worchester, Massachusetts
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Program Overview
Manisha H. Shah, MD
The Ohio State University, Columbus, Ohio
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Defining the Spectrum of Differentiated Thyroid Cancer: A Clinical Perspective
Lilah F. Morris-Wiseman, MD
Banner University Medical Center, Tucson , Arizona
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Defining the Spectrum of Differentiated Thyroid Cancer: A Histological and Molecular Perspective
Thomas J. Giordano , MD, PhD
University of Michigan, Ann Arbor, Michigan
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Active Surveillance in Differentiated Thyroid Cancer
Wendy Sacks, MD
Cedars-Sinai Medical Center, Los Angeles, California
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Challenging the Minimalist Approach to Surgical Intervention in Differentiated Thyroid Cancer
Ralph P. Tufano, MD, MBA, FACS
Johns Hopkins University School of Medicine, Baltimore, Maryland
Challenging the Minimalist Approach to Surgical Intervention in Differentiated Thyroid Cancer
Mona M. Sabra, MD
Memorial Sloan-Kettering Cancer Center, New York, New York
Challenging the Minimalist Approach to Surgical Intervention in Differentiated Thyroid Cancer
Carmen C. Solórzano, MD, FACS
Vanderbilt University, Nashville, Tennessee
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Controversies in Radioactive Iodine Adjuvant Therapy: Which patients? How much to give?
Stephanie L. Lee, MD, PhD
Boston University Medical Center, Boston, Massachusetts
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Controversies in Radioactive Iodine Adjuvant Therapy: Which patients? How much to give?
David S. Cooper, MD, MACP
Johns Hopkins University School of Medicine, Baltimore, Maryland
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Controversies in Radioactive Iodine Adjuvant Therapy: Which patients? How much to give?
Kenneth D. Burman, MD
MedStar Washington Hospital Center, Washington, DC
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Systemic Therapy Options: Standard of Care and Beyond for Advanced Differentiated Thyroid Cancer
Manisha H. Shah, MD
The Ohio State University, Columbus, Ohio
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Insights and Surprises from an Online Survey of Thyroid Cancer Patients
Elizabeth Gardner Grubbs, MD, MS, FACS
The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Insights and Surprises from an Online Survey of Thyroid Cancer Patients
Mara Y. Roth, MD
University of Washington, Seattle, Washington
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Questions and Answers
Manisha H. Shah, MD
The Ohio State University, Columbus, Ohio
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Welcome
John C. Morris III, MD
Mayo Clinic, Rochester, MN
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Introduction
Antonio C. Bianco, MD, PhD
Rush University Medical Center, Chicago, IL
Introduction
Jacqueline Jonklaas, MD
Georgetown University Medical Center, Washington, DC
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Understanding the Evolution of Therapies for Hypothyroidism
James V. Hennessey, MD
Beth Israel Deaconess Medical Center, Boston, MA
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Whose Normal TSH is Better, Yours or Mine?
Peter N. Taylor, Bsc, MBChB, MSc
Cardiff University School of Medicine, Cardiff, United Kingdom
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Beyond TSH: T3 Levels and Deiodinase Polymorphisms
Antonio C. Bianco, MD, PhD
Rush University Medical Center, Chicago, IL
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Debate: Where Do We Stand on Combination Therapy?
Douglas S. Ross, MD
Massachusetts General Hospital, Boston, MA
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Debate: Where Do We Stand on Combination Therapy?
Colin M. Dayan, MA, MBBC, FRCP, PhD
Cardiff University School of Medicine, Cardiff, United Kingdom
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Debate: Where Do We Stand on Combination Therapy? Questions and Answers
Douglas S. Ross, MD
Massachusetts General Hospital, Boston, MA
Debate: Where Do We Stand on Combination Therapy? Questions and Answers
Colin M. Dayan, MA, MBBC, FRCP, PhD
Cardiff University School of Medicine, Cardiff, United Kingdom
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Knowledge Gaps: Which Thyroid Measurements Are Relevant and How Does Diet Impact Thyroid Function?
Anne R. Cappola, MD
University of Pennsylvania School of Medicine, Philadelphia, PA
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Quality of Life Considerations in Hypothyroidism Treatment
Anna M. Sawka, MD
Toronto General Hospital, University of Toronto, Toronto, ON, Canada
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
ATA Hypothyroidism Treatment Patient Survey
M. Regina Castro, MD
Mayo Clinic, Rochester, MN
ATA Hypothyroidism Treatment Patient Survey
Alan P. Farwell, MD
Boston Medical Center, Boston, MA
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Panel Discussion: Hypothyroidism – A Patient's Perspective
Alan P. Farwell, MD
Boston Medical Center, Boston, MA
Panel Discussion: Hypothyroidism – A Patient's Perspective
M. Regina Castro, MD
Mayo Clinic, Rochester, MN
Panel Discussion: Hypothyroidism – A Patient's Perspective
Judy O'Reilly
Retired, Winter Garden, FL
Panel Discussion: Hypothyroidism – A Patient's Perspective
Kimberly Dorris, MBA
Graves' Disease and Thyroid Foundation, Rancho Santa Fe, CA
Panel Discussion: Hypothyroidism – A Patient's Perspective
Philip James
Doctor Thyroid, Portland, OR
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
2016 ATA Clinical Guidelines: Management of Hyperthyroidism
Assessing the Etiology of Thyrotoxicosis, Choice of Therapy, Subclinical Hyperthyroidism
Douglas S Ross, MD
Massachusetts General Hospital, Waban, MA
from 2016 ATA Clinical Guidelines on the Management of Hyperthyroidism and Thyroid Illness During Pregnancy on March 31, 2016 1:00 PM-3:15 PM
<< first | < prev next > | last >>
presentations: 1 to 25 of 484
page: of 20 per page